Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Hospira, Inc., a Pfizer company, is voluntarily recalling 8 lots of Hospira ’s Daptomycin for Injection 500 mg, Lyophilized Powder For Solution, Single Dose Vial (NDC 0409-0106-01) to the Hospital/Retail level. The product is being recalled due to adverse event reports indicative of infusion reactions.

https://www.fda.gov/Safety/Recalls/ucm613488.htm

Source: Food and Drug Administration - July 13, 2018 Category: Food Science Source Type: news

More News: Cubicin | Food and Drug Administration (FDA) | Food Science | Hospitals | Pfizer